Viz.ai Adds PE Stratification | Liver Cancer Blood Test
![](https://www.signifyresearch.net/wp-content/uploads/2023/10/download-1.png)
![Dr Sanjay M Parekh headshot](https://www.signifyresearch.net/wp-content/uploads/2024/01/Sanjay-Updated-New-for-Website-150x150.jpg)
Dr Sanjay M Parekh
Published: September 5, 2022 In The News
5th September 2022 – Contribution by Sanjay Parekh – Featured on ImagingWire.com
Viz.ai is So On-Trend – Signify Research recently forecast that AI leaders will increasingly expand into new clinical segments, enhance their current solutions, and leverage platform / marketplace strategies, as AI evolves from point solutions to comprehensive workflows. Those trends are certainly evident within Viz.ai’s recent PE strategy.
You may also like